COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus

Click to access mobile menu
Print
  • Share:
Skip Navigation LinksHome > Programs and Activities > ODS Seminars, Conferences, and Workshops > Role of Iron in Alcoholic Liver Disease

Notice: Historical Content
This is an archival or historical document and may not reflect current data.

Role of Iron in Alcoholic Liver Disease


Role of Iron in Alcoholic Liver Disease

Sponsored by: National Institute on Alcohol Abuse and Alcoholism
and the
Office of Dietary Supplements

Friday, October 25, 2002
Hyatt Regency, Bethesda, MD


Organizer:

    Vishnudutt Purohit, Ph.D.
    Program Director
    Biomedical Research Branch/Division of Basic Research
    National Institute on Alcohol Abuse and Alcoholism
    National Institutes of Health
    6000 Executive Boulevard/ suite 402
    Bethesda, M.D., 20892-7003
    Phone: (301) 443-2689; Fax: (301) 594-0673
    E-mail: vpurohit@willco.niaaa.nih.gov

Agenda:

7:45 - 8:30 Breakfast
8:30 - 8:40 Opening Remarks
Sam Zakhari, Ph.D., NIAAA/NIH
Paul Coates, Ph.D., ODS/NIH
8:40 - 9:00 Introduction to the Symposium
Vishnudutt Purohit, Ph.D., NIAAA/NIH
Christine Swanson, Ph.D., ODS/NIH
Morning Session: Chairperson: Bin Gao, M.D., Ph.D., NIAAA/NIH
9:00 - 9:40 An Overview of Iron Metabolism
Tracy Rouault, M.D., NICHD/NIH
9:40 - 10:20 Iron-Dependent Macrophage Cell Activation in Alcoholic Liver Disease
Hidekazu Tsukamoto, D.V.M., Ph.D., University of Southern California
10:20 - 10:50 Break
10:50 - 11:30 Iron and CYP2E1-Induced Oxidative Stress in Alcoholic Liver Disease
Arthur I. Cederbaum, Ph.D., Mount Sinai School of Medicine, New York
11:30 - 12:10 Iron-Induced Oxidant Stress and Liver Fibrogenesis
Antonello Pietrangelo, M.D., Ph.D., University of Modena and Reggio Emilia, Italy
12:10 - 1:15 Lunch
Afternoon Session: Chairperson: Denise Russo, Ph.D., NIAAA/NIH
1:15 - 1:55 Hemochromatosis and Alcoholic Liver Disease
Lawrie W. Powell, M.D., Ph.D., The Queensland Institute of Medical Research, Australia
1:55 - 2:35 Iron in non-Hemochromatic Liver Diseases
Herbert Bonkovsky, M.D., University of Connecticut Health Center, Connecticut
2:35 - 3:00 Break
3:00 - 3:40 Iron and Cancer
Yves Deugnier, M.D., Service des Maladies du Foie CHU Pontchaillou, France
3:40 - 4:20 Iron Chelators and Iron Toxicity
Gary M. Brittenham, M.D., Columbia University, New York
4:20 - 5:20 Discussion
David Brenner, M.D., University of North Carolina at Chapel Hill
Patricia Greenwel, Ph.D., CSR/NIH